Pharmaceuticals are increasingly recognized as a major class of emerging contaminants in aquatic environments, particularly in surface waters and wastewater-impacted systems. Despite their generally moderate environmental persistence and occurrence at trace levels, their continuous release leads to chronic exposure, raising concerns about long-term ecological effects. In recent years, the inclusion of several antibiotics in the European Union Watch List has highlighted the relevance of pharmaceutical pollution, particularly in relation to the environmental presence and spread of antimicrobial resistance (AMR), identified by the WHO as a critical global health threat. Beyond antibiotics, other therapeutic classes such as NSAIDs, antidepressants… can interfere with key physiological processes in aquatic plants, microalgae and fish, inducing community-level alterations and sub-lethal effects. The aim of this work was to develop and validate a robust, high-sensitivity UHPLC-MS/MS multi-residue analytical strategy capable of simultaneously determining pharmaceuticals and metabolites at trace levels in complex aquatic matrices, while ensuring applicability to environmental monitoring and risk assessment frameworks. Method development was specifically designed to address analytical challenges posed by environmental samples, including matrix complexity and the wide physicochemical diversity of target compounds. A UHPLC-MS/MS method was developed and validated for the simultaneous determination of 26 pharmaceuticals and metabolites belonging to critical therapeutic classes, including beta-lactams, macrolides, fluoroquinolones, sulphonamides, lincosamides and diaminopyrimidines, as well as NSAIDs, antifungals, and anti-depressants.The analytical workflow involved rigorous optimisation of chromatographic conditions, electrospray ionisation in positive mode(ESI+/) and Multiple Reaction Monitoring parameters. To ensure maximum sensitivity and selectivity, different sample pre-treatment approaches were comparatively evaluated, including filtration with metal cation chelation followed by direct injection, online SPE and offline SPE. The validated method demonstrated high analytical performance, with limits of detection (LOD) and quantification (LOQ) in the ng/L range, strong linearity (R² > 0.98) and recoveries exceeding 75% for most analytes.Supporting regulation and understanding AMR environmental risk.
High-sensitivity UHPLC-MS/MS multi-residue analysis of pharmaceuticals in aquatic systems: Methodological advances for environmental risk and AMR assessment / Pacchione, G., Bollella, A., Nigro Di Gregorio, F.. - (2026). (10th EuChemS Chemistry Congress. Anversa ).
High-sensitivity UHPLC-MS/MS multi-residue analysis of pharmaceuticals in aquatic systems: Methodological advances for environmental risk and AMR assessment.
Guglielmo Pacchione;Alessandro Bollella;Federica Nigro di Gregorio
2026
Abstract
Pharmaceuticals are increasingly recognized as a major class of emerging contaminants in aquatic environments, particularly in surface waters and wastewater-impacted systems. Despite their generally moderate environmental persistence and occurrence at trace levels, their continuous release leads to chronic exposure, raising concerns about long-term ecological effects. In recent years, the inclusion of several antibiotics in the European Union Watch List has highlighted the relevance of pharmaceutical pollution, particularly in relation to the environmental presence and spread of antimicrobial resistance (AMR), identified by the WHO as a critical global health threat. Beyond antibiotics, other therapeutic classes such as NSAIDs, antidepressants… can interfere with key physiological processes in aquatic plants, microalgae and fish, inducing community-level alterations and sub-lethal effects. The aim of this work was to develop and validate a robust, high-sensitivity UHPLC-MS/MS multi-residue analytical strategy capable of simultaneously determining pharmaceuticals and metabolites at trace levels in complex aquatic matrices, while ensuring applicability to environmental monitoring and risk assessment frameworks. Method development was specifically designed to address analytical challenges posed by environmental samples, including matrix complexity and the wide physicochemical diversity of target compounds. A UHPLC-MS/MS method was developed and validated for the simultaneous determination of 26 pharmaceuticals and metabolites belonging to critical therapeutic classes, including beta-lactams, macrolides, fluoroquinolones, sulphonamides, lincosamides and diaminopyrimidines, as well as NSAIDs, antifungals, and anti-depressants.The analytical workflow involved rigorous optimisation of chromatographic conditions, electrospray ionisation in positive mode(ESI+/) and Multiple Reaction Monitoring parameters. To ensure maximum sensitivity and selectivity, different sample pre-treatment approaches were comparatively evaluated, including filtration with metal cation chelation followed by direct injection, online SPE and offline SPE. The validated method demonstrated high analytical performance, with limits of detection (LOD) and quantification (LOQ) in the ng/L range, strong linearity (R² > 0.98) and recoveries exceeding 75% for most analytes.Supporting regulation and understanding AMR environmental risk.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


